Nanomedicine is an emerging field with a large potential for developing public welfare and economic growth. Critical issues for bringing up this potential in Europe concern especially the maturity of the economic players and their capability to move effectively innovation from knowledge to industrial technology and to clinical and public health applications. Industrial players need therefore to co ...